Cardiovascular disease is one of the most important causes of death worldwide. The number of people hospitalized due to cardiovascular disease is rapidly increasing by about 4 times from 2002 to 2018 in Korea. Cardiac biomarkers not only have played an essential role in the diagnosis of myocardial disease, but also they can be used for the purpose of risk stratification of
cardiovascular disease in asymptomatic patients. Recently international guidelines show expanded indications of cardiac biomarkers for non-cardiac surgery and diabetic patients.
Abbott’s core lab business is helping to transform healthcare around the world through a broad range of innovative instrument platforms, tests and services. We are addressing the growing needs of our customers for greater efficiencies through the use of analytics, informatics and automation. Our newest innovation, the Alinity harmonized family of solutions, is a huge leap forward in diagnostics. It includes technologies for clinical chemistry and immunoassay, hematology, molecular, point of care, and blood screening. This new, advanced platform was designed to be more efficient while providing fast, accurate test results that can be used to make timely treatment decisions.
CLINICAL CHEMISTRY, IMMUNOASSAY AND INTEGRATED SYSTEMS TO TRANSFORM YOUR LABORATORY. The Alinity ci-series consists of compact, scalable systems to maximize throughput and efficiency, making today's high-performing laboratories run at their best, today and into the future.
AN ADVANCED TOTAL LABORATORY AUTOMATION SOLUTION To help your laboratory thrive now and in the future, Abbott is pleased to introduce GLP Systems, an advanced total laboratory automation solution, offering you proven technology with more flexibility and options to meet your goals. FREEDOM TO CHANGE - Reduce the risk of implementing a long-term solution with an innovative track design SIMPLICITY THROUGH INTUITIVE DESIGN – Relieve the pain of change that often comes with adopting a new automation system EXCELLENCE IN PERFORMANCE – Focus on critical laboratory tasks, not maintaining uptime.
ID NOW™ is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Our unique ID NOW™ isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner.
TEST1 is a fully automated analyzer for the measurement of the Erythrocyte Sedimentation Rate.(E.S.R). This system is an innovative system which is capable of using only 175ul sample volumes to test even for pediatric patient. The very short time for 18.5 seconds is required to detect E.S.R to allow the performance of serial tests on the same patient offering the possibility of following up the evolution inflammatory pathologies.